Joint WHO, WIPO, WTO Technical Symposium on Access to Medicines: Pricing and Procurement Practices
16 July 2010 in Geneva
Summary and key issues
Opening Remarks: Creating Synergies Between Intellectual Property Rights and Public Health
- M Pascal Lamy, Director-General, World Trade Organization (WTO)
- Dr Margaret Chan, Director-General, World Health Organization (WHO)
- M Francis Gurry, Director General, World Intellectual Property Organization (WIPO)
Presentations: Current Developments and Ongoing Work in WHO/WTO/WIPO
- Procurement, prequalification, pricing, availability of drugs, Richard Laing, WHO [pdf 1.23MB]
- Relevant multilateral trade policies and available data, Antony Taubman, WTO [pdf 6.57MB]
- Access to patent information, competition policy, arbitration and mediation, Konji Sebati, WIPO [pdf 79kb]
Discussion moderator: Zafar Mirza, WHO
Presentations: Consumption Pricing and Availability
- Data on pricing, Thuy Huong Ha and Sophie Logez, The Global Fund [pdf 492kb]
- Medicine prices, availability, affordability & price components, Margaret Ewen, Health Action International (HAI) [pdf 1.12MB]
Discussion moderator: Carsten Fink, WIPO
Presentations: Experiences on Medicines Procurement
Katy Athersuch, Medical Innovation & Access Policy Adviser, Médecins Sans Frontières Campaign for Access to Essential Medicines (no presentation available)
Presentations: Taking Stock and Defining Future Needs
Jorge Bermudez, UNITAID (no presentation available)
Rebecca Stevens, International Federation of Pharmaceutical Manufacturers Association (Novartis) (no presentation available)
Denis Broun, Joint United Nations Programme on HIV/AIDS (UNAIDS) (no presentation available)
Discussion moderator: Antony Taubman, WTO